Dr. Joseph Charles Poen, MD

Dr. Poen practices at Novato Community Hospital in Novato, California, part of Sutter Health.

Dr. Poen's NPI, 1972585941, was assigned on November 16, 2005. Dr. Poen graduated from David Geffen School of Medicine at UCLA in 1988. Dr. Poen's California license number on file is G66706.

Dr. Poen's primary practice is Novato Community Hospital, at 180 Rowland Way, Novato, CA 94945 in Marin County. The practice phone is (415) 209-1300.

Dr. Poen's primary practice is Novato Community Hospital in Novato, California, part of Sutter Health. Dr. Poen is also affiliated with UCSF Helen Diller Medical Center at Parnassus Heights. The medical group on file is Marin Cancer Care. Dmand AI also links Dr. Poen to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Poen practices, 5 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Poen's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Poen is board certified in radiation oncology by the American Board of Radiology. Dr. Poen has a license on file in California.

Dmand AI lists anal cancer radiation, bladder cancer radiation, bone cancer radiation, brain tumor radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Poen treats.

CMS data shows 3,099 Medicare services from Dr. Poen across 20 procedure codes in 2024, for 223 Medicare patients. Medicare paid $225,436 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 223 Medicare patients who saw Dr. Poen in 2024. The largest group is 75 to 84, with 108 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Poen's median patient age at 77, with 41% women.

In 2024, Dr. Poen wrote 171 Medicare Part D claims for 55 patients. 95% of them were for generic drugs. CMS names the drug for 60 of them, across 2 drugs with 11 or more claims each, at $807 in total drug cost. In 2023, CMS named 64 claims across 4 drugs.

Dr. Poen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Poen as offering telehealth.

Dmand AI links 7 papers to Dr. Poen. The most frequent topics are Pancreatic Neoplasms, Radiotherapy Dosage and Feasibility Studies. Dr. Poen has published most often in Int J Radiat Oncol Biol Phys. Dr. Poen's most frequent co-authors are James Matthew Ford, MD, John R. Adler, MD and Jefferson Augusto Bastidas, MD.

CMS Open Payments shows 20 general payments to Dr. Poen from 10 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Progenics Pharmaceuticals, Inc. paid the most, $125.

Dr. Poen graduated from David Geffen School of Medicine at UCLA in 1988.

Dr. Poen is in network with 8 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.